Blocking of its receptor IL-17RB with SM17 may just offer inhibitory effects on these disease-contributing cytokines all at once (62), which could result in better restoration in normal lung histology and reduction in asthma exacerbations. The gene discussed is IL17RB; the disease is asthma.